205 related articles for article (PubMed ID: 26699276)
1. Ganglioside-Dependent Neural Stem Cell Proliferation in Alzheimer's Disease Model Mice.
Koon NA; Itokazu Y; Yu RK
ASN Neuro; 2015; 7(6):. PubMed ID: 26699276
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effects of G(M1) ganglioside and amyloid β-peptide on mouse embryonic neural stem cells.
Yanagisawa M; Ariga T; Yu RK
ASN Neuro; 2010 Mar; 2(1):e00029. PubMed ID: 20305711
[TBL] [Abstract][Full Text] [Related]
3. Amyloid β-peptide 1-42 modulates the proliferation of mouse neural stem cells: upregulation of fucosyltransferase IX and notch signaling.
Itokazu Y; Yu RK
Mol Neurobiol; 2014 Aug; 50(1):186-96. PubMed ID: 24436056
[TBL] [Abstract][Full Text] [Related]
4. Effects of amyloid β-peptides and gangliosides on mouse neural stem cells.
Itokazu Y; Kato-Negishi M; Nakatani Y; Ariga T; Yu RK
Neurochem Res; 2013 Oct; 38(10):2019-27. PubMed ID: 23851714
[TBL] [Abstract][Full Text] [Related]
5. Amyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimer's disease pathology with ganglioside metabolism.
Grimm MO; Zinser EG; Grösgen S; Hundsdörfer B; Rothhaar TL; Burg VK; Kaestner L; Bayer TA; Lipp P; Müller U; Grimm HS; Hartmann T
PLoS One; 2012; 7(3):e34095. PubMed ID: 22470521
[TBL] [Abstract][Full Text] [Related]
6. Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: expression of Chol-1α antigens in the brain.
Ariga T; Yanagisawa M; Wakade C; Ando S; Buccafusco JJ; McDonald MP; Yu RK
ASN Neuro; 2010 Oct; 2(4):e00044. PubMed ID: 20930939
[TBL] [Abstract][Full Text] [Related]
7. Brain gangliosides of a transgenic mouse model of Alzheimer's disease with deficiency in GD3-synthase: expression of elevated levels of a cholinergic-specific ganglioside, GT1aα.
Ariga T; Itokazu Y; McDonald MP; Hirabayashi Y; Ando S; Yu RK
ASN Neuro; 2013 May; 5(2):141-8. PubMed ID: 23565921
[TBL] [Abstract][Full Text] [Related]
8. Altered Nup153 Expression Impairs the Function of Cultured Hippocampal Neural Stem Cells Isolated from a Mouse Model of Alzheimer's Disease.
Leone L; Colussi C; Gironi K; Longo V; Fusco S; Li Puma DD; D'Ascenzo M; Grassi C
Mol Neurobiol; 2019 Aug; 56(8):5934-5949. PubMed ID: 30689197
[TBL] [Abstract][Full Text] [Related]
9. Allopregnanolone enhances the neurogenesis of midbrain dopaminergic neurons in APPswe/PSEN1 mice.
Zhang P; Xie MQ; Ding YQ; Liao M; Qi SS; Chen SX; Gu QQ; Zhou P; Sun CY
Neuroscience; 2015 Apr; 290():214-26. PubMed ID: 25637494
[TBL] [Abstract][Full Text] [Related]
10. Promoted CD4
Wu X; Shen Q; Chang H; Li J; Xing D
J Neuroinflammation; 2022 Oct; 19(1):253. PubMed ID: 36217178
[TBL] [Abstract][Full Text] [Related]
11. Characterization of an 'Amyloid Only' Transgenic (B6C3-Tg(APPswe,PSEN1dE9)85Dbo/Mmjax) Mouse Model of Alzheimer's Disease.
Finnie GS; Gunnarsson R; Manavis J; Blumbergs PC; Mander KA; Edwards S; Van den Heuvel C; Finnie JW
J Comp Pathol; 2017 May; 156(4):389-399. PubMed ID: 28431735
[TBL] [Abstract][Full Text] [Related]
12. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC
Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997
[TBL] [Abstract][Full Text] [Related]
13. Proliferation, differentiation and amyloid-β production in neural progenitor cells isolated from TgCRND8 mice.
Kanemoto S; Griffin J; Markham-Coultes K; Aubert I; Tandon A; George-Hyslop PS; Fraser PE
Neuroscience; 2014 Mar; 261(100):52-9. PubMed ID: 24361736
[TBL] [Abstract][Full Text] [Related]
14. Neural stem cell transplants improve cognitive function without altering amyloid pathology in an APP/PS1 double transgenic model of Alzheimer's disease.
Zhang W; Wang PJ; Sha HY; Ni J; Li MH; Gu GJ
Mol Neurobiol; 2014 Oct; 50(2):423-37. PubMed ID: 24481678
[TBL] [Abstract][Full Text] [Related]
15. Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer's disease.
Yang W; Chauhan A; Wegiel J; Kuchna I; Gu F; Chauhan V
Curr Alzheimer Res; 2014; 11(10):1002-11. PubMed ID: 25387339
[TBL] [Abstract][Full Text] [Related]
16. 3D Culture Method for Alzheimer's Disease Modeling Reveals Interleukin-4 Rescues Aβ42-Induced Loss of Human Neural Stem Cell Plasticity.
Papadimitriou C; Celikkaya H; Cosacak MI; Mashkaryan V; Bray L; Bhattarai P; Brandt K; Hollak H; Chen X; He S; Antos CL; Lin W; Thomas AK; Dahl A; Kurth T; Friedrichs J; Zhang Y; Freudenberg U; Werner C; Kizil C
Dev Cell; 2018 Jul; 46(1):85-101.e8. PubMed ID: 29974866
[TBL] [Abstract][Full Text] [Related]
17. Gangliosides in Nerve Cell Specification.
Itokazu Y; Wang J; Yu RK
Prog Mol Biol Transl Sci; 2018; 156():241-263. PubMed ID: 29747816
[TBL] [Abstract][Full Text] [Related]
18. APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease.
Manocha GD; Floden AM; Rausch K; Kulas JA; McGregor BA; Rojanathammanee L; Puig KR; Puig KL; Karki S; Nichols MR; Darland DC; Porter JE; Combs CK
J Neurosci; 2016 Aug; 36(32):8471-86. PubMed ID: 27511018
[TBL] [Abstract][Full Text] [Related]
19. Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model.
Yu Y; He J; Zhang Y; Luo H; Zhu S; Yang Y; Zhao T; Wu J; Huang Y; Kong J; Tan Q; Li XM
Hippocampus; 2009 Dec; 19(12):1247-53. PubMed ID: 19309037
[TBL] [Abstract][Full Text] [Related]
20. Early Impairments of Hippocampal Neurogenesis in 5xFAD Mouse Model of Alzheimer's Disease Are Associated with Altered Expression of SOXB Transcription Factors.
Zaletel I; Schwirtlich M; Perović M; Jovanović M; Stevanović M; Kanazir S; Puškaš N
J Alzheimers Dis; 2018; 65(3):963-976. PubMed ID: 30103323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
